Richard Levy
Directeur/Bestuurslid bij MADRIGAL PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jesse Shefferman | M | 52 | 7 jaar | |
| Paul Friedman | M | 81 | 8 jaar | |
| David Block | M | 64 |
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 17 jaar |
| John Borgeson | M | 62 | 8 jaar | |
| Herve Hoppenot | M | 64 | 10 jaar | |
| Felix Baker | M | 55 | 9 jaar | |
| Rebecca Taub | M | 71 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 12 jaar |
| Victor Perlroth | M | 51 | 15 jaar | |
| Fred Craves | M | 78 | 13 jaar | |
| Mark Ragosa | M | 50 | 6 jaar | |
| Jacqueline Zummo | M | 43 | 7 jaar | |
| Eben Tessari | M | 42 | 9 jaar | |
| James Daly | M | 63 | 9 jaar | |
| William Sibold | M | - | 1 jaar | |
| Sanj Patel | M | 54 | 9 jaar | |
| Edward Chiang | M | - | 13 jaar | |
| Luke Beshar | M | 65 | 6 jaar | |
| Barry Flannelly | M | 66 | 10 jaar | |
| Michael Megna | M | 53 | 6 jaar | |
| Gregory Sargen | M | 59 | 5 jaar | |
| Ken Bate | M | 73 | 8 jaar | |
| Julian Baker | M | 57 | 1 jaar | |
| Madelyn Zeylikman | F | - | 4 jaar | |
| Jane Huang | M | 51 | 3 jaar | |
| Robert Profusek | M | 73 | 6 jaar | |
| Justine O'Malley | M | - | 4 jaar | |
| Thomas Tray | M | 46 | 19 jaar | |
| Tai Yin Yang | M | 70 | 5 jaar | |
| Barry Quart | M | 67 | 9 jaar | |
| Rachel Frank | F | - | - | |
| Cynthia Smith | F | 55 | 3 jaar | |
| Tracey McCain | F | 56 | 6 jaar | |
| Charles Bancroft | M | 65 | 4 jaar | |
| Michael Solomon | M | 54 | 6 jaar | |
| Kim Popovits | F | 65 | 6 jaar | |
| G. Cole | M | 68 | 4 jaar | |
| Stephen Biggar | M | 53 | 9 jaar | |
| Bassil Dahiyat | M | 53 | 6 jaar | |
| Hannah Fry | F | 34 | 4 jaar | |
| Paul Clancy | M | 62 | 9 jaar | |
| Mary J. Grendell | F | - | - | |
| Thomas Malley | M | 55 | 8 jaar | |
| Jean-Jacques Bienaimé | M | 70 | 9 jaar | |
| Roger Garceau | M | 70 | 5 jaar | |
| Robert Waltermire | M | 60 | 3 jaar | |
| Kyle Rusconi | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 3 jaar |
| Stephen Dodge | M | - | - | |
| Carole Huntsman | F | - | - | |
| Pablo Velazquez-Martin | M | - | - | |
| Ross Moat | M | 43 | 5 jaar | |
| Almas Qudrat | F | - | 6 jaar | |
| Mark Barrett | M | - | - | |
| Charles Polsky | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Peter Langmuir | M | - | 9 jaar | |
| Martina Struck | M | - | 6 jaar | |
| Melissa Manno | F | - | 7 jaar | |
| Michael Morrissey | M | - | 8 jaar | |
| David Broser | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Tina Ventura | F | - | - | |
| Christopher Frates | M | - | 3 jaar | |
| Catalina Loveman | F | - | 9 jaar | |
| Steven Stein | M | 57 | 9 jaar | |
| John Paolini | M | 59 | 8 jaar | |
| Scott Strome | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Patrick Fabbio | M | 56 | 1 jaar | |
| Brian Lynch | M | 62 | 5 jaar | |
| Mark Lerner | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 10 jaar |
| Raymond Schinazi | M | 74 |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Ronald Filippo | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Roy Whitfield | M | 70 | 23 jaar | |
| Richard de Schutter | M | 83 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 14 jaar |
| Thomas Beetham | M | 55 | 6 jaar | |
| Christopher Heberlig | M | 49 | 5 jaar | |
| Scott Braunstein | M | 60 | 2 jaar | |
| Marc R. Schneebaum | M | 69 | 7 jaar | |
| Stephen Mahoney | M | 53 | 4 jaar | |
| Lloyd Mackenzie | M | 56 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 10 jaar |
| Laurent Chardonnet | M | 59 | - | |
| Bryant Lim | M | 53 | 4 jaar | |
| Krishna Vaddi | M | 58 | 13 jaar | |
| Paul Trower | M | 54 | 18 jaar | |
| Eric Siegel | M | 60 | - | |
| Shelley McCloskey | F | 64 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 3 jaar |
| Blaine Davis | M | 50 | 2 jaar | |
| Alex Howarth | M | 55 | 3 jaar | |
| David Milligan | M | 83 | 7 jaar | |
| Scott W. Hurley | M | 65 | - | |
| Joseph Papa | M | 68 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | - |
| Sean Nolan | M | 56 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 4 jaar |
| Barry Michael Ariko | M | 78 | 14 jaar | |
| David Hastings | M | 62 | 11 jaar | |
| Elias Bendekgey | M | 66 | 6 jaar | |
| Michael D. Casey | M | 78 | 17 jaar | |
| John F. Niblack | M | 85 | - | |
| Barbara Troupin | M | 56 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 2 jaar |
| Carsten Boess | M | 57 | 5 jaar | |
| Patricia A. Schreck | F | 70 | 8 jaar | |
| Wendy Dixon | M | 68 | 12 jaar | |
| Ashley Garry | M | - | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 95 | 95.96% |
| Canada | 4 | 4.04% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Richard Levy
- Persoonlijk netwerk